Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,432
Closed -$308K 260
2025
Q1
$308K Buy
3,432
+1
+0% +$93 0.07% 167
2024
Q4
$341K Buy
3,431
+94
+3% +$9.69K 0.07% 155
2024
Q3
$379K Hold
3,337
0.08% 141
2024
Q2
$413K Buy
3,337
+1
+0% +$129 0.1% 134
2024
Q1
$440K Buy
3,336
+103
+3% +$12.7K 0.11% 135
2023
Q4
$352K Hold
3,233
0.09% 152
2023
Q3
$333K Hold
3,233
0.1% 148
2023
Q2
$373K Buy
3,233
+105
+3% +$11.9K 0.11% 143
2023
Q1
$333K Buy
3,128
+265
+9% +$28.6K 0.1% 154
2022
Q4
$318K Hold
2,863
0.11% 155
2022
Q3
$247K Buy
2,863
+38
+1% +$3.39K 0.09% 175
2022
Q2
$258K Sell
2,825
-935
-25% -$82.9K 0.09% 171
2022
Q1
$309K Hold
3,760
0.09% 175
2021
Q4
$288K Hold
3,760
0.07% 186
2021
Q3
$282K Hold
3,760
0.08% 186
2021
Q2
$292K Sell
3,760
-19
-0.5% -$1.41K 0.08% 171
2021
Q1
$278K Buy
+3,779
New +$279K 0.08% 176
2020
Q3
Sell
-7,538
Closed -$556K 226
2020
Q2
$556K Buy
+7,538
New +$567K 0.21% 114

Other funds holding MRK

SkyOak Wealth's MRK Position: Q2 2025 in Review

SkyOak Wealth sold out of Merck (MRK) in Q2 2025, closing a stake of 3,432 shares — an estimated $308K sold.

SkyOak Wealth first reported a position in MRK in Q2 2020 and held it in 18 quarters. The position peaked at $556K in Q2 2020. 3,327 funds tracked by Wall St. Rank hold MRK as of Q2 2025.

  • SkyOak Wealth reported no remaining Merck position as of Q2 2025 after selling out during the quarter.
  • SkyOak Wealth sold 3,432 Merck shares in Q2 2025, an estimated $308K.
  • SkyOak Wealth first reported a position in Merck in Q2 2020 and held it in 18 quarters.
  • SkyOak Wealth's Merck position peaked at $556K in Q2 2020.
  • 3,327 funds tracked by Wall St. Rank held Merck as of Q2 2025.

Based on SkyOak Wealth's 13F filing for Q2 2025, filed 30 Jul 2025.